These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 26805390)

  • 1. Digoxin in patients with atrial fibrillation and heart failure: A risk factor or a marker of increased mortality?
    Huang Y; Huang W; Hu Y
    Int J Cardiol; 2016 Mar; 206():171-2. PubMed ID: 26805390
    [No Abstract]   [Full Text] [Related]  

  • 2. Reply to the letter "Digoxin in patients with atrial fibrillation and heart failure: A risk factor or a marker of increased mortality".
    Bavishi C; Khan AR; Ather S
    Int J Cardiol; 2016 Mar; 206():56-7. PubMed ID: 26774832
    [No Abstract]   [Full Text] [Related]  

  • 3. Digoxin in patients with atrial fibrillation and heart failure: A meta-analysis.
    Bavishi C; Khan AR; Ather S
    Int J Cardiol; 2015 Jun; 188():99-101. PubMed ID: 25900519
    [No Abstract]   [Full Text] [Related]  

  • 4. Digoxin use in patients with atrial fibrillation and adverse cardiovascular outcomes: a retrospective analysis of the Rivaroxaban Once Daily Oral Direct Factor Xa Inhibition Compared with Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation (ROCKET AF).
    Washam JB; Stevens SR; Lokhnygina Y; Halperin JL; Breithardt G; Singer DE; Mahaffey KW; Hankey GJ; Berkowitz SD; Nessel CC; Fox KA; Califf RM; Piccini JP; Patel MR;
    Lancet; 2015 Jun; 385(9985):2363-70. PubMed ID: 25749644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Digoxin and atrial fibrillation in 2016].
    Théone S; Carballo S; Carballo D; Marti C
    Rev Med Suisse; 2016 Oct; 12(535):1758-1760. PubMed ID: 28692216
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Digoxin use and risk of mortality in hypertensive patients with atrial fibrillation.
    Okin PM; Hille DA; Wachtell K; Kjeldsen SE; Boman K; Dahlöf B; Devereux RB
    J Hypertens; 2015 Jul; 33(7):1480-6. PubMed ID: 25799208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of Digoxin on Mortality in Patients With Atrial Fibrillation Stratified by Heart Failure: Findings From Gulf Survey of Atrial Fibrillation Events in the Middle East.
    Al-Zakwani I; Panduranga P; Zubaid M; Sulaiman K; Rashed WA; Alsheikh-Ali AA; AlMahmeed W; Shehab A; Al Qudaimi A; Asaad N; Amin H
    J Cardiovasc Pharmacol Ther; 2016 May; 21(3):273-9. PubMed ID: 26341119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutical considerations in associated atrial fibrillation and heart failure.
    Mitu O; Mitu F; Constantin S; Cojocaru E; Leon MM
    Rev Med Chir Soc Med Nat Iasi; 2014; 118(3):624-30. PubMed ID: 25341275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relation of digoxin use in atrial fibrillation and the risk of all-cause mortality in patients ≥65 years of age with versus without heart failure.
    Shah M; Avgil Tsadok M; Jackevicius CA; Essebag V; Behlouli H; Pilote L
    Am J Cardiol; 2014 Aug; 114(3):401-6. PubMed ID: 24950677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Digoxin Is Associated With Increased All-cause Mortality in Patients With Atrial Fibrillation Regardless of Concomitant Heart Failure: A Meta-analysis.
    Wang ZQ; Zhang R; Chen MT; Wang QS; Zhang Y; Huang XH; Wang J; Yan JH; Li YG
    J Cardiovasc Pharmacol; 2015 Sep; 66(3):270-5. PubMed ID: 26348825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment with maintenance dose of digoxin; an analysis of 102 cases].
    Yang ZB; Li S
    Zhonghua Xin Xue Guan Bing Za Zhi; 1980 Mar; 8(1):20-2. PubMed ID: 7449612
    [No Abstract]   [Full Text] [Related]  

  • 12. Predictors of digoxin use and risk of mortality in ED patients with atrial fibrillation.
    Wu S; Yang YM; Zhu J; Ren JM; Wang J; Zhang H; Shao XH
    Am J Emerg Med; 2017 Nov; 35(11):1589-1594. PubMed ID: 28551087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The characteristics of digoxin utilization in a population under emergency care for heart failure or auricular fibrillation].
    Mundet X; Vidal X; Arnau JM
    Med Clin (Barc); 1993 Jan; 100(3):94-7. PubMed ID: 8426500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Digoxin - time to take the gloves off?
    Eade E; Cooper R; Mitchell AR
    Int J Cardiol; 2013 Apr; 164(3):365-7. PubMed ID: 21807421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Digoxin prescribing for heart failure in elderly residents of long-term care facilities.
    Misiaszek B; Heckman GA; Merali F; Turpie ID; Patterson CJ; Flett N; McKelvie RS
    Can J Cardiol; 2005 Mar; 21(3):281-6. PubMed ID: 15776118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Digoxin in the aged.
    Kirsten E; Rodstein M; Iuster Z
    Geriatrics; 1973 Jan; 28(1):95-101. PubMed ID: 4683094
    [No Abstract]   [Full Text] [Related]  

  • 17. Supervised withdrawal of long-term digoxin therapy.
    Fair JF
    Fam Pract; 1990 Mar; 7(1):56-9. PubMed ID: 2318375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Digoxin Use in Atrial Fibrillation; Insights From National Ambulatory Medical Care Survey.
    Anwar MN; Khan UA; Khakwani AS; Saeed I; Ishfaq H; Muslim MO; Anwaar MF
    Curr Probl Cardiol; 2023 Aug; 48(8):101209. PubMed ID: 35460684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of digoxin for heart failure and atrial fibrillation in elderly patients.
    Cheng JW; Rybak I
    Am J Geriatr Pharmacother; 2010 Oct; 8(5):419-27. PubMed ID: 21335295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Digoxin mortality in heart failure and atrial fibrillation.
    Tofield A
    Eur Heart J; 2015 Aug; 36(30):1944-5. PubMed ID: 26478930
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.